Lincoff, A M, Nicholls, S J, Riesmeyer, J S, Barter, P J, Brewer, H B, Fox, K A A, Gibson, C M, Granger, C, Menon, V, Montalescot, G, Rader, D, Tall, A R, McErlean, E, Wolski, K, Ruotolo, G, Vangerow, B, Weerakkody, G, Goodman, S G, Conde, D, McGuire, D K, Nicolau, J C, Leiva-Pons, J L, Pesant, Y, Li, W, Kandath, D, Kouz, S, Tahirkheli, N & Mason, D & Nissen, S E 2017, ' Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease ', New England Journal of Medicine, vol. 376, no. 20, pp. 1933-1942 . https://doi.org/10.1056/NEJMoa1609581
New England Journal of Medicine New England Journal of Medicine, Massachusetts Medical Society, 2019, 380 (4), pp.347-357. ⟨10.1056/NEJMoa1812389⟩ NEW ENGLAND JOURNAL OF MEDICINE
Lancet Diabetes & Endocrinology r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname The Lancet Diabetes & Endocrinology Volume 7 Issue 8 Ray, K K, Colhoun, H M, Szarek, M, Baccara-Dinet, M, Bhatt, D L, Bittner, V A, Budaj, A J, Diaz, R, Goodman, S G, Hanotin, C, Harrington, R A, Jukema, J W, Loizeau, V, Lopes, R D, Moryusef, A, Murin, J, Pordy, R, Ristic, A D, Roe, M T, Tuñón, J, White, H D, Zeiher, A M, Schwartz, G G, Steg, P G & ODYSSEY OUTCOMES Committees and Investigators 2019, ' Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes : a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial ', The Lancet Diabetes and Endocrinology, vol. 7, no. 8, pp. 618-628 . https://doi.org/10.1016/S2213-8587(19)30158-5 Ray, K K, Colhoun, H M, Szarek, M, Baccara-Dinet, M, Bhatt, D L, Bittner, V A, Budaj, A J, Diaz, R, Goodman, S G, Hanotin, C, Harrington, R A, Jukema, J W, Loizeau, V, Lopes, R D, Moryusef, A, Murin, J, Pordy, R, Ristic, A D, Roe, M T, Tuñón, J, White, H D, Zeiher, A M, Schwartz, G G, Steg, P G & ODYSSEY OUTCOMES Committees and Investigators 2019, ' Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes : a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial ', The Lancet Diabetes & Endocrinology, vol. 7, no. 8, pp. 618-628 . https://doi.org/10.1016/S2213-8587(19)30158-5 Lancet diabetes & endocrinology ODYSSEY OUTCOMES Committees and Investigators 2019, ' Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes : a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial ', The Lancet Diabetes and Endocrinology, vol. 7, no. 8, pp. 618-628 . https://doi.org/10.1016/S2213-8587(19)30158-5 Ray, K K, Colhoun, H M, Szarek, M, Baccara-Dinet, M, Bhatt, D L, Bittner, V A, Budaj, A J, Diaz, R, Goodman, S G, Hanotin, C, Harrington, R A, Jukema, J W, Loizeau, V, Lopes, R D, Moryusef, A, Murin, J, Pordy, R, Ristic, A D, Roe, M T, Tunon, J, White, H D, Zeiher, A M, Schwartz, G S, Steg, P G, Schwartz, G G, Steg, P G, ODYSSEY OUTCOMES Committees and Investigators, Clemmensen, P, Gislason, G, Nielsen, P K, Davidsen, F, Andersen, D, Jeppesen, J & Videbæk, L 2019, ' Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial ', The Lancet Diabetes & Endocrinology, vol. 7, no. 8, pp. 618-628 . https://doi.org/10.1016/S2213-8587(19)30158-5 r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA Lancet Diabetes and Endocrinology, 7(8), 618-628. ELSEVIER SCIENCE INC
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname Goodman, S G, Aylward, P E, Szarek, M, Chumburidze, V, Bhatt, D L, Bittner, V A, Diaz, R, Edelberg, J M, Hanotin, C, Harrington, R A, Jukema, J W, Kedev, S, Letierce, A, Moryusef, A, Pordy, R, Lopez, G A R, Roe, M T, Viigimaa, M, White, H D, Zeiher, A M, Steg, P G, Schwartz, G G, ODYSSEY OUTCOMES Committees and Investigators, Clemmensen, P, Gislason, G, Davidsen, F & Videbaek, L 2019, ' Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery ', Journal of the American College of Cardiology, vol. 74, no. 9, pp. 1177-1186 . https://doi.org/10.1016/j.jacc.2019.07.015 Journal of the American College of Cardiology, 74(9), 1177-1186. ELSEVIER SCIENCE INC
Circulation Steg, P G, Szarek, M, Bhatt, D L, Bittner, V A, Bregeault, M-F, Dalby, A J, Diaz, R, Edelberg, J M, Goodman, S G, Hanotin, C, Harrington, R A, Jukema, J W, Lecorps, G, Mahaffey, K W, Moryusef, A, Ostadal, P, Parkhomenko, A, Pordy, R, Roe, M T, Tricoci, P, Vogel, R, White, H D, Zeiher, A M, Schwartz, G G, ODYSSEY OUTCOMES Committees and Investigators, Clemmensen, P, Gislason, G, Davidsen, F & Videbaek, L 2019, ' Effect of Alirocumab on Mortality After Acute Coronary Syndromes : An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial ', Circulation, vol. 140, no. 2, pp. 103-112 . https://doi.org/10.1161/CIRCULATIONAHA.118.038840 CIRCULATION r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname Circulation, 140(2), 103-112. LIPPINCOTT WILLIAMS & WILKINS Circulation : an official journal of the American Heart Association 140(2), 103-112 (2019). doi:10.1161/CIRCULATIONAHA.118.038840
Circulation: Cardiovascular Quality and Outcomes, 12(11). LIPPINCOTT WILLIAMS & WILKINS Circulation : cardiovascular quality and outcomes Circulation-Cardiovascular Quality and Outcomes r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname Circulation-cardiovascular Quality And Outcomes, 12(11). Lippincott Williams & Wilkins Szarek, M, Steg, P G, DiCenso, D, Bhatt, D L, Bittner, V A, Budaj, A, Diaz, R, Goodman, S G, Gotcheva, N N, Jukema, J W, Pordy, R, Roe, M T, Sourdille, T, White, H D, Xavier, D, Zeiher, A M, Schwartz, G G, ODYSSEY OUTCOMES Committees and Investigators, Gislason, G, Davidsen, F & Videbaek, L 2019, ' Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial ', Circulation: Cardiovascular Quality and Outcomes, vol. 12, no. 11, e005858 . https://doi.org/10.1161/CIRCOUTCOMES.119.005858
The New England Journal of Medicine, 376, 16, pp. 1527-1539 New England Journal of Medicine New England Journal of Medicine, Massachusetts Medical Society, 2017, 376 (16), pp.1527-1539. ⟨10.1056/NEJMoa1701488⟩ New England Journal of Medicine, 376(16), 1527-1539. MASSACHUSETTS MEDICAL SOCIETY New England Journal of Medicine, 376(16), 1527. Massachussetts Medical Society The New England Journal of Medicine, 376, 1527-1539 Department of Medicine Publications Ridker, P M, Revkin, J, Amarenco, P, Brunell, R, Curto, M, Civeira, F, Flather, M, Glynn, R J, Gregoire, J, Jukema, J W, Karpov, Y, Kastelein, J J P, Koenig, W, Lorenzatti, A, Manga, P, Masiukiewicz, U, Miller, M, Mosterd, A, Murin, J, Nicolau, J C, Nissen, S, Ponikowski, P, Santos, R D, Schwartz, P F, Soran, H, White, H, Wright, R S, Vrablik, M, Yunis, C, Shear, C L, Tardif, J-C, SPIRE Cardiovascular Outcome Investigators & Michael Jepsen, J 2017, ' Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients ', The New England Journal of Medicine, vol. 376, no. 16, pp. 1527-1539 . https://doi.org/10.1056/NEJMoa1701488 New England Journal of Medicine, 376(16), 1527-1539 Zaguán. Repositorio Digital de la Universidad de Zaragoza instname New England journal of medicine, 376(16), 1527-1539. Massachussetts Medical Society
The New England journal of medicine, vol. 372, no. 25, pp. 2387-2397 Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual) Universidade de São Paulo (USP) instacron:USP Cannon, C P, Blazing, M A, Giugliano, R P, McCagg, A, White, J A, Theroux, P, Darius, H, Lewis, B S, Ophuis, T O, Jukema, J W, De Ferrari, G M, Ruzyllo, W, De Lucca, P, Im, K, Bohula, E A, Reist, C, Wiviott, S D, Tershakovec, A M, Musliner, T A, Braunwald, E, Califf, R M, IMPROVE-IT Investigators & Clemmensen, P M 2015, ' Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes ', The New England Journal of Medicine, vol. 372, no. 25, pp. 2387-2397 . https://doi.org/10.1056/NEJMoa1410489 New England Journal of Medicine New England Journal of Medicine, Massachusetts Medical Society, 2015, 372 (25), pp.2387-97. ⟨10.1056/NEJMoa1410489⟩ New England Journal of Medicine, 372(25), 2387-2397 New England journal of medicine, 372(25), 2387-2397. Massachussetts Medical Society